https://www.selleckchem.com/pr....oducts/sbi-0640756.h
Moreover, SCU was able to reverse aggrecan and collagen II degradation and nuclear factor-κB (NF-κ and nuclear factor erythroid-derived 2-like 2 (Nrf2) signaling pathway activation both in vivo and in vitro. We further used a destabilization of the medial meniscus (DMM) murine model of OA to explore the therapeutic benefits of SCU in vivo. Together, our findings suggest SCU to be a potentially valuable therapeutic agent useful for treating OA. Copyright © 2020 Luo, Hu, Bian, Su, Li, Li, Wu, Shi, Song, Zheng, Ni and Xue.Ferulic aci